Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

The distressing impact of rare diseases

Much more needs to be done to address the problem of effective communications with stakeholders and adequate information for patients affected

- PMLiVE

Developing therapeutic cancer vaccines

Dendreon’s success has paved the way for new candidates

- PMLiVE

PPD set to conduct more clinical trials in Germany

Signs research collaboration with Charité–Universitätsmedizin Berlin

- PMLiVE

UCB names Jean-Christophe Tellier as Doliveux’s successor

He will take over take over leadership at the Belgium pharma company next year

- PMLiVE

GSK’s Anoro backed in Europe for COPD

CHMP recommendation set to expand pharma company’s respiratory portfolio

- PMLiVE

CURx buys rights to Gilead’s lung infection drug

Agrees deal for fosfomycin/tobramycin combination

Biogen Idec building

NICE turns down Biogen Idec’s oral MS drug

UK HTA body says Tecfidera is not a cost-effective use of NHS resources

- PMLiVE

Merck KGaA appoints biosimilar head

Simon Sturge joins from Boehringer Ingelheim

- PMLiVE

LinkedIn adds a pharma ‘influencer’

Pfizer CEO Ian Read joins the likes of Bill Gates and Richard Branson in writing for the social network

- PMLiVE

Genesis Burson-Marsteller partners with Medulla in India

Companies will work together in growing Indian healthcare market

- PMLiVE

Interview: Phil Southerland, Team Novo Nordisk

The man behind the world's first all-diabetes cycling team

- PMLiVE

Makara Health celebrates first birthday and new offices

Takes up residence at the University of Southampton Science Park

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links